Austrian researchers identify persistent immune protein as biomarker for complications of Long COVID-19.
Researchers identified PTX-3 as a potential biomarker for lasting tissue damage, chronic immune activation, and post-infection complications, shedding light on Long COVID and ME/CFS biological mechanisms.
Source: https://archive.li/WB5AE
Study:

Frontiers | Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3










